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Abstract 
THE EFFECT OF ADDING DRAG-REDUCING POLYMERS TO RESUSCITATION 
FLUID DURING HEMORRHAGIC SHOCK ON SKELETAL MUSCLE 
MICROCIRCULATION 
By Geoffrey C. Alexander 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Major Director: Roland N. Pittman, Ph.D. 
Professor Department of Physiology 
Previous studies have shown an increase in survival when a minute amount of drag- 
reducing polymers were added to a resuscitation fluid. The purpose of this investigation 
was to examine the effect of adding a minute amount of the drag-reducing polymer 
polyethylene glycol to a resuscitation fluid, on the microcirculation of skeletal muscle 
during a volume-controlled hemorrhage model. The spinotrapezius muscle in twelve male 
Sprague Dawley rats was exteriorized for microvascular measurements of the arterioles. 
The diameters of the three levels of arterioles, interstitial fluid POz, and RBC velocity in 
the feed arteriole were measured. Flow in the feed arteriole was calculated using the 
xi 
diameter and RBC velocity. Heart rate, mean arterial pressure, respiratory rate, arterial 
blood gases, arterial blood electrolytes, and arterial blood metabolites were measured. No 
significant physiological differences were observed between the DRP group and the 
Control group. 
Introduction 
The single major cause of death in potentially salvageable battlefield casualties is 
hemorrhage (Bellamy 1984; Rhee, Koustova et al. 2003). Trauma is the leading cause of 
death among civilians younger than 40 years old (National Vital Statistics Reports 2002; 
Macias, Kameneva et al. 2004). Trauma accounts for approximately 150,000 fatalities and 
many prolonged illnesses despite advances in patient care (National Vital Statistics Reports 
2002; Kameneva, Wu et al. 2004). Hemorrhage may be responsible for as many as 50% of 
all deaths within the first 24 hours after traumatic injury (Sauaia, Moore et al. 1994; 
Moore, Sauaia et al. 1996; Heckbert, Vedder et al. 1998). Thus, hemorrhagic shock is a 
significant public health problem. New diagnostic and treatment strategies are needed to 
improve the survival of the patients who may have otherwise survived their injuries. 
Hemorrhagic Shock 
Definition 
Hemorrhagic shock occurs when blood loss exceeds the body's ability to 
compensate for the loss. Shock is the consequence of insufficient tissue perfusion, 
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resulting in inadequate cellular oxygenation and an accumulation of metabolic wastes. The 
consequences of untreated shock are metabolic derangements that result in a vicious 
cascade that includes hypothermia, acidosis, and coagulopathy. If unresolved, shock 
progresses to an irreversible state, resulting in multisystem organ failure and death 
(Mullins 2000). 
Without intervention, a classic trimodal distribution of deaths is seen in severe 
hemorrhagic shock. An initial peak of mortality occurs within minutes of hemorrhage due 
to immediate exsanguination. Another peak occurs after one to several hours due to 
progressive decompensation. A third peak occurs days to weeks later due to sepsis and 
organ failure (Bozeman 2004). 
Resuscitation 
The focus of treatment of hemorrhagic shock is hemorrhage control and 
reestablishing organ perfusion and tissue oxygenation through volume expansion. 
Resuscitation usually begins with infusion of isotonic crystalloid fluid, followed by 
administration of packed red blood cells. Other fluid resuscitation strategies have been 
tested, ranging from the use of hypertonic and hyperoncotic solutions aimed at maintaining 
circulating volumes longer, to the use of artificial hemoglobin-based oxygen carriers, to 
permissive hypotension that reduces circulatory pressures and thus hemorrhage. (Haljamae 
1985; Mattox, Maningas et al. 199 1; Bickell, Wall et al. 1994; Sloan, Koenigsberg et al. 
1999; Nolan 200 1 ; Bellomo 2002; Moore 2003). None of these more recent approaches 
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have been clinically accepted in the United States. These treatments are mainly based on 
systemic vital signs such as blood pressure and heart rate (ACS (ed.) 1997). Current 
treatments have ignored the importance of the microcirculation as an organ system itself, 
which may be a target for therapy (Messmer and Kreimeier 1989; Corso, Okamoto et al. 
1998). 
The Blood and Circulation 
Oxygen is a vital component required to sustain the life of cells in the mammalian 
body. To meet the continuous metabolic demands of cells in tissues for oxygen, mammals 
evolved a system to transport oxygen from its uptake in the lungs to its delivery sites in the 
tissues via blood. The main function of the circulatory system is to transport and distribute 
essential substances to tissues (oxygen and nutrients), and remove by-products of 
metabolism (carbon dioxide, lactic acid, etc.). This system also is involved in other bodily 
functions, including hormone transport from their sites of production to their sites of action 
(endocrine system), and immunity (white blood cells and the immune system). Blood also 
participates in homeostatic mechanisms such as aiding in the distribution of water, solutes, 
and heat, and the adjustment of oxygen and nutrient supply under various physiologic 
states (Berne and Levy 2004). 
Composition of Blood 
Approximately 6-7% of body weight is accounted for by circulating blood volume. 
(McGuill and Rowan 1989) About 45% of blood volume consists of blood cells. The 
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blood cells are classified into three different types: red blood cells, white blood cells, and 
platelets. There are 4.5-5.5 million red cells, 7,000-12,000 white cells, and 150,000- 
400,000 platelets per microliter of blood. Blood cells are suspended in a complex solution 
(plasma). Plasma accounts for approximately 55% of blood volume and is a mixture of 
gases, salts, proteins, carbohydrates, and lipids (Berne and Levy 2004). 
Oxygen Transport in Blood 
Oxygen transported within the blood takes two forms: dissolved in plasma and 
bound to hemoglobin (Weibel 1984). Dissolved oxygen comprises a very small portion of 
the total oxygen content of blood (2%) and accounts for the partial pressure of oxygen in 
blood. The amount of dissolved oxygen in blood is unable to meet the oxygen 
requirements of the tissues. Oxygen reversibly bound to hemoglobin comprises the vast 
majority of the total oxygen content of blood (98%). The oxygen content of blood is 
determined by the oxygen binding capacity and the concentration of hemoglobin (Costanzo 
2006). 
Oxygen Transport and Exchange through Vessels 
Oxygen is transported throughout the body through a circulatory system comprised 
of four parts: the heart (pump), arteries (distribution vessels), capillaries (exchange 
vessels), and veins (collecting vessels) (Weibel 1984). The heart is basically two pumps in 
series: one pump sends deoxygenated blood through the lungs to exchange carbon dioxide 
and oxygen (the pulmonary circulation) and the other pump propels oxygenated blood 
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returning to the heart fi-om the lungs to all other tissues of the body (the systemic 
circulation) (Berne and Levy 2004). 
Larger arteries branch into smaller ones which in turn branch into arterioles. The 
branches narrow and their walls become thinner as they approach the periphery. Frictional 
resistance due to viscosity increases as the arteries get smaller with the maximal collective 
resistance in the arterioles. Variation in the degree of contraction of the circular muscle of 
the small arteries and arterioles permits regulation of tissue blood flow and aids in the 
control of arterial blood pressure (Berne and Levy 2004). 
Arising fi-om arterioles are capillaries, vessels whose walls are composed of only a 
single layer of endothelial cells and whose lumen constrains red blood cells to travel in a 
single file (Berne and Levy 2004; Costanzo 2006). Blood from the capillaries empties into 
venules and then through veins of increasing size on its way back to the heart. 
Oxygen transport into the tissue takes place at the level of the microcirculation 
(Costanzo 2006). The niicrocirculation is the collection of blood vessels that are small 
enough so as to require a magnified image to visualize clearly. The microcirculatory 
network is composed of series and parallel connections of arterioles, capillaries, and 
venules (Pittman 2006). All of these vessels can participate in oxygen exchange because 
their walls are permeable to oxygen and POz differences exist between their lumens and 
the interstitial fluid (Ellsworth et al. 1994; Pittman 2006). 
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The capillary design is maximized for the local diffusion of oxygen down a 
gradient into the mitochondria1 sinks created by oxidative phosphorylation (Weibel 1984). 
Capillaries exhibit the greatest surface-area-to-volume ratio in the microcirculation 
(Costanzo, 2006). Red blood cell velocity is low and gas diffusion distance is minimized 
by the close proximity of capillaries to the surrounding tissue (Pittman 1995; Berne and 
Levy 2004). 
Convection and Diffusion 
Oxygen is transported through two different processes: convection (the mass 
transport of oxygen in blood by bulk flow) and diffusion (the net movement of oxygen 
driven by a partial pressure gradient) ( ~ e i b e l  1984; Pittman 2000) (See Figure 1.1). 
Convective flow of oxygen through a vessel can be expressed by the following (Pittman 
1995): 
Equation 1 
~ 0 2 ~ ~ ~ "  = Cm [Hb] x R~ V SO2 
Where CHb is the oxygen binding capacity of hemoglobin, [Hb] is the concentration of 
hemoglobin, R is the internal radius of the vessel, V is the average velocity of blood, and 
SO2 is the fractional oxygen saturation of the red blood cell hemoglobin. 
Diffusive flow of oxygen (QOzDIFF) can be determined by the application of Fick's 
Principle, a statement of the conservation of mass whereby the oxygen consumption in a 
tissue must equal the amount of oxygen in the arterial inflow minus the amount of oxygen 
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in the venous outflow over a period of time. This concept can also be applied to single 
blood vessels: 
Equation 2 
~ 0 2 ~ ' ~ ~  = ~ 0 2 ~ ~ '  (upstream) - ~ 0 ~ " ~ '  (downstream) 
where ~ 0 2 " ~ '  is convective flow of oxygen (Pittman 1995; Pittman 2000). 
However, the passive diffusion of oxygen through a capillary wall can also be expressed 
by Fick's Law of diffusion: 
Equation 3 
~ 0 2 ~  = - DaA AP02/Ax 
where ~ 0 2 ~  is the quantity of oxygen moved per unit time, D is the free diffusion 
coefficient for oxygen, a is the oxygen solubility coefficient, A is the surface area for 
diffusion, and APOz/Ax is the partial pressure gradient (APO2 is the partial pressure 
difference of oxygen and Ax is the diffusion distance) (Berne and Levy 2004; Pittman 
2000). The PO2 gradient is large and the diffusion distance is short within the pulmonary 
capillaries (0.5 pm). The transfer of oxygen is not diffusion-limited in the pulmonary 
circulation. In contrast, in the tissues, diffusion is limited because the diffusion distance 
(Ax) is much greater (10's of pm). Capillary recruitment and thus an increase in capillary 
density and a large capillary surface area account for the ability of diffusion to serve as the 
primary mechanism in the exchange of gases and waste products between capillaries and 
the tissue cells of the body (Berne and Levy 2004). 
Figure 1.1 Pictorial representation of the diffusive flow of oxygen by the application 
of Fick's principle. 
(From Pittman 1995) 
Figure 1.1 
QO~DIFF - Q O ~ ~ ~ ~ ~  (upstream) - ~ 0 2 ~ ' ~ ~  (downstream) 
Q O Z ~ O ~ "  = CHb [Hb] A R~ V SO2 
Drag-Reducing Polymers 
Background 
In 1949 following World War I1 British chemist B.A. Toms first described the 
ability of soluble, high molecular weight (MW > lo6 Da) polymers so-called Drag- 
Reducing Polymers characterized by long chains, relatively linear structure, and unique 
elastic properties to reduce resistance to turbulent flow in a pipe (Kameneva, Wu et al. 
2004) (See Figure 1.2). This decrease in resistance allows an increase in flow rate under a 
constant pressure or a decrease in pressure under a constant flow (Kameneva, Wu et al. 
2004). D m ' s  do not change the viscosity of fluid at the effective concentrations, nor do 
they affect flow resistance under laminar flow conditions. However, DRP additives 
reduced hydrodynamic resistance in systems with noniurbulent (disturbed laminar) flows, 
such as pulsating flow in straight and spiral pipes (Keller, Kiss et al. 1975; Driels and 
Ayyash 1976; Kameneva, Wu et al. 2004). The Toms effect has been intensively 
investigated for decades and has been utilized for various industrial applications (Lumley 
1969; Shenoy 1984; Kulicke, Kotter, and Grager 1989; Savins 1995; Singh, Singh et al. 
1995; Kameneva, Wu et al. 2004). D m ' s  have been used to ease the flow of oil in the 
Alaskan pipeline, to increase well pressures for enhanced oil recovery and, in firefighting, 
to make water shoot farther from fire hose nozzles. The U.S. Navy has long been interested 
in using drag-reducing polymers to help submarines and surface ships move with greater 
stealth and less power (Spice 2004). The exact mechanisms underlying the Toms effect 
remain incompletely understood (Kameneva, Wu et al. 2004). 
Figure 1.2 Pictorial representation of the molecular shape of Drag-Reducing 
Polymers. Poly(ethy1ene oxide) (PEO) is a polymer composed by sequences of 
-(CH2CH2)0)- monomeric units. 
Figure. 1.2 
Drag-Reducing Polymers in the Circulation 
The flow conditions associated with the Toms effect probably do no occur when 
blood flows through arteries, arterioles, capillaries, venules, and veins. However, several 
studies have shown DRP's to produce positive hemodynamic effects in various acute and 
chronic animal models (Polimeni, Ottenbreit et al. 1985; Coleman, Ottenbreit et al. 1987; 
Hutchison, Campbell et al. 1989; Polimeni and Ottenbreit 1989; Unthank, Lalka et al. 
1992; Sokolova, Shakhnazarov et al. 1993; Sawchuk, Unthank et al. 1999; Kameneva, Wu 
et al. 2004; Macias, Kameneva et al. 2004). Minute concentrations of these polymers 
administered intravenously caused an increase in aortic and arterial blood flow and a 
decrease in both blood pressure and peripheral vascular resistance, with no effect on blood 
viscosity or blood vessel tone (Polimeni, Ottenbreit et al. 1985; Coleman, Ottenbreit et al. 
1987; Polimeni and Ottenbreit 1989; Kameneva, Wu et al. 2004). DRP's were found to 
significantly increase collateral blood flow in rabbits (Gannushkina, Grigorian et al. 198 I), 
increase the number of the functional capillaries in normal and diabetic rats (Golub, 
Grigorian et al. 1987), and reduce hydrodynamic resistance in both normal and adenosine- 
dilated rat mesentery arterioles (Sokolova, Shakhnazarov et al. 1993). 
Purpose of Present Study 
A very small number of studies involving DRP's and hemorrhage have been 
published. However, those studies show an increase in survivability when a minute 
amount of DRP's are added to a resuscitation fluid (Kamevena, Wu et al. 2004; Macias, 
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Kameneva et al. 2004). The reason for the increased survivability to a severe hemorrhage 
is still unknown. None of those studies focused on the direct affect DRP's had on the 
microcirculation. Therefore, the purpose of this investigation was to examine the effect of 
adding a minute amount of the DRP polyethylene glycol to a resuscitation fluid, on the 
microcirculation of skeletal muscle in a volume-controlled hemorrhage model. 
Specifically, the diameters of the three levels of arterioles, interstitial fluid PO2, and RBC 
velocity in the feed arteriole were measured. Flow in the feed arteriole was calculated 
using the diameter and RBC velocity. Heart rate, mean arterial pressure, respiratory rate, 
arterial blood gases, arterial blood electrolytes, and arterial blood metabolites were 
measured and compared to corresponding values in control animals. 
MATERIALS AND METHODS 
All procedures were approved by the Virginia Commonwealth University 
Institutional Animal Care and Use Committee (protocol # 0407-2976) and are consistent 
with the National Institutes of Health guidelines for the humane treatment of laboratory 
animals, as well as the American Physiological Society's Guiding Principles in the Care 
and Use of Animals. 
Anesthesia and Animal Preparation 
Twelve male Sprague-Dawley rats (Harlan, Indianapolis, IN) weighing 250-300 
grams were housed in plastic containers at 20-23 "C on a 12: 12 hour 1ight:dark cycle, and 
allowed access to food and water ad libitum under the supervision of a certified animal 
care technician. 
In preparation for the experiment, the animal was weighed on a triple beam 
balance. The mass was recorded and total blood volume was calculated as 6% of total 
body mass. Hemorrhage volume was calculated as 40% of the total blood volume. The 
animal was initially anesthetized with an intraperitoneal injection of a ketamine and 
acepromazine mixture (72 mgkg ketamine 1 3 mgkg acepromazine). The animal was 
then shaved along its neck, back, and ventral right groin with clippers, and a depilatory 
cream (Nair) was used to remove any remaining hair in the area. The animal was placed in 
the supine position on a homeothermic blanket system, complete with rectal temperature 
probe (Harvard Apparatus), to maintain body temperature at ~ 3 7  "C for cannulations and 
muscle exteriorization. 
Tracheal and Vascular Cannulations 
First, a small midline incision was made in the anterior neck over the trachea. The 
subcutaneous tissue was dissected, and the sternohyoid muscle was split longitudinally by 
blunt dissection to expose the trachea. The trachea was isolated, incised, and cannulated 
with polyethylene tubing (PE 240) to maintain a patent airway for the remainder of the 
experiment. The skin incision was then extended inferiorly and to the right in order to 
expose the jugular vein as it passed over the clavicle. The jugular vein was cannulated 
with polyethylene tubing (PE 90) for resuscitation fluid infusion. 
The right carotid artery was then exposed in the crease between the sternohyoid 
muscle and the mastoid portion of the sternocephalic muscle. The right carotid artery was 
cannulated with polyethylene tubing (PE 90-PE 50 combination). The carotid artery was 
used for withdrawal of blood during hemorrhage procedures and blood sampling for 
arterial blood gas, metabolite, electrolyte, pH (ABL 705, Radiometer America Inc., 
Westlake, OH), and oxygenation measurements (Radiometer OSM3, Radiometer, Crawley, 
West Sussex, UK). 
An incision was made in the crease of the ventral right groin where the abdomen 
and right hind leg meet. The femoral artery and vein were exposed and separated by blunt 
dissection. The femoral artery was cannulated with fluid-filled polyethylene tubing (PE 
50-PE 10 combination) and the femoral vein was cannulated with polyethylene tubing (PE 
50). Arterial pressure was measured continuously through the femoral catheter. The 
femoral vein was used for supplemental anesthetic infusion. At this point, continuous 
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intravenous infusion of alfaxalone/alfadolone (Saffan, Schering-Plough Animal Health, 
Welwyn Garden City, UP, 0.1 mg/kg/min) was initiated for maintenance anesthesia. The 
anesthetic rate was adjusted as needed to maintain the surgical plane of anesthesia, as 
evidenced by the absence of a toe pinch reflex and stable vital signs (i.e., HR, MAP, and 
RR). Heparanized saline (20 units of heparinlml of normal saline) or continuous infusion 
of fluid ensured patency of all vascular lines. 
Spinotrapezius Muscle Preparation 
The spinotrapezius muscle was used for measurement of microcirculatory 
hemodynamics and interstitial PO2 (PIsFOZ), and the surgical preparation was similar to the 
original description by Gray (Gray 1973). It is a thin muscle that originates on the spinous 
processes of the thoracic and lumbar vertebrae and inserts on the scapula. The muscle is 
approximately 6 cm long, 1.5 cm wide, and 500 pm thick, and has a mixed fiber type 
distribution, (Delp and Duan 1996). To expose this muscle, a dorsal midline incision was 
initiated at the level of the lumbar vertebrae and extended superiorly to the level of the 
scapula. The underlying subcutaneous tissue was carefully removed to minimize bleeding 
and prevent trauma to the muscle. As a M h e r  measure to prevent trauma to the 
preparation, a thin strap muscle running parallel to the lateral border of the spinotrapezius 
was used for surgical manipulation and suturing. The muscle was separated from deeper 
tissues along its lateral border by blunt dissection using Metzenbaum scissors. As the 
lateral border was freed, the strap muscle was sutured with 5 cm lengths of 5-0 silk suture 
at 1 cm intervals to minimize trauma to the spinotrapezius and to facilitate surgical and 
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experimental muscle manipulation. The dissection continued until the lateral, inferior, and 
medial borders were freed from the deeper muscle tissue, or cut from their attachment, and 
sutured, while the superior border was left intact. The muscle was kept moist throughout 
the surgical procedure by adding Ringer's solution topically, and bleeding was controlled 
by a cautery unit. This method of preparation leaves the supplying nerve and vasculature 
intact, and microvascular fbnction is maintained (Bailey, Kindig et al. 2000). 
Once the spinotrapezius muscle was isolated, the animal was transferred to a 
custom-made thermostatic microscope platform as described by Golub and Pittman (Golub 
and Pittman 2003) and modified by Lowman (Lowman 2004). The unit consisted of an 
adjustable platform for the animal's body, and a pedestal onto which the spinotrapezius 
muscle was placed. Platform and pedestal temperatures were separately controlled by 
electronic heating units (Heaterstat temperature controller, model CT698- 1005T39CL 1, 
Minco Products, Inc., Minneapolis, MN), which were adjusted separately to maintain body 
and muscle temperatures at - 37 "C. The muscle tissue was then moistened with a Ringer 
solution and covered with plastic film (Saran, Dow Corning, Midland, MI) to minimize 
desiccation and atmospheric gas exchange. In order to minimize the possibility of 
exposure of the preparation to the atmosphere, the muscle was fastened to the pedestal by 
the sutures and the plastic film was taped to the pedestal. 
Video Microscopy 
A 100-watt halogen lamp was used to transilluminate the muscle, and the 
microvasculature was observed with a Zeiss Axioplan 2 microscope equipped with an 
Achroplan objective (20X, NA=0.45). A Leitz 20XNA 0.33 objective (model) was 
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adapted for use as a condenser. This set-up, combined with the shortened height of the 
tissue viewing window on the thermostatic platform, allowed Kohler illumination and 
significantly improved transilluminated image quality compared with that using the 
original platform design. Images of the microcirculation were recorded on videotape 
(CCD-72 camera, MTI, Michigan City, IN; AG-DS555 Panasonic VCR and Viero Flat 
Panel Monitor, Panasonic, Secaucus, NJ) with a total magnification of 1 lOOX at the 
monitor. The signal output from the camera was monitored on an oscilloscope. Centerline 
red blood cell velocity was measured with an Optical Doppler Velocimeter 
(Cardiovascular Research Institute, Texas A&M Health Sciences Center, College Station, 
TX), and vessel luminal diameter was measured with an image-shearing monitor (Model 
908, Instrumentation for Physiology and Medicine, San Diego, CA). Output from both 
devices was recorded with a Biopac MP-150 (BIOPAC Systems Inc., Goleta, CA)(200 Hz 
sampling rate), and measurements were averaged over 10 seconds. See Fig. 2.1 for a 
schematic diagram of the microscope set-up. 
Figure 2.1 Schematic of the microscope set-up for intravital microscopy and 
phosphorescence quenching microscopy 
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Phosphorescence Quenching Microscopy 
Principle of the Method 
Phosphorescence quenching microscopy (PQM) is a minimally-invasive, optical 
technique that can measure PO2 with a high degree of spatial and temporal resolution. It 
utilizes a phosphorescent molecule as an oxygen probe that can be injected into the 
vasculature or topically applied to the tissue. When excited by light, phosphorescent 
molecules are raised to the triplet state, and return to the ground state by emitting light, a 
process known as phosphorescence. Additionally, the molecule can return to the ground 
state by transferring energy to other molecules, thereby decreasing the duration of the 
phosphorescence decay - a process known as quenching. Oxygen is the principal 
quenching agent in biological tissues, and the rate of quenching is diffusion-limited. The 
oxygen dependence of the phosphorescence decay is described by the Stern-Volmer 
equation 
Equation 4 
k = k,  + k,  PO, 
where k is phosphorescence decay rate (= l/z, the lifetime) at the measured PO2, ko is the 
phosphorescence decay rate in the absence of oxygen (llz o), and k,  is the quenching 
coefficient. However, in the presence of oxygen gradients, as occur in vivo, the use of the 
Stern-Volmer equation under the assumption of uniform PO2 can lead to systematic 
underestimates of mean PO2 (Golub, Pope1 et al. 1999). Golub, Pope1 et al. (1999) 
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proposed a model (Rectangular distribution) that accounts for non-uniform oxygen levels 
in the measurement region, and therefore minimizes ,the systematic error inherent in 
calculating PO2 using a monoexponential function. P I ~ ~ O ~  as calculated using the 
following equation: 
Equation 5 
Y t  = A  expl- (k,, + k, M)] .  sinh(k,&)l k,& + B exp(- t 1 F) + 
where A is the amplitude of the phosphorescence signal, ko is the phosphorescence decay 
rate in the absence of oxygen, kq is the quenching coefficient, M is the mean PO2, 6 is the 
half width of the PO2 distribution, B is the amplitude of the fast post-excitation transient, F 
is the lifetime of the fast post-excitation transient, and yo is the baseline offset. The values 
for constants ko and kq, 18.3.10~ p-' and 3.06.10'~ ps-tmm~g", respectively, were 
determined in separate calibration experiments (Zheng, Golub et al. 1996). 
Preparation and application of the phosphorescent pro be 
Palladium meso-tetra (4 carboxyphenyl) porphyrin (Pd-MTCPP, Oxygen 
Enterprises, Ltd., Philadelphia, PA) was bound to bovine serum albumin in solution, then 
dialyzed in polyvinylpyrrolidine for 24 hours to remove any unbound probe from the 
solution. Trizma base was added as needed to adjust the pH to 7.3-7.5, and the solution 
was filtered, pipetted into micro-centrifuge tubes, and kept frozen until later use. At the 
time of the experiment, 0.4 ml of the Pd-MTCPP solution was thawed for topical 
administration. A piece of no. 2 filter paper was soaked in the phosphor solution, then 
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wrapped around the spinotrapezius muscle in order to expose both surfaces of the muscle 
to the solution. The filter paper, as well as all exposed tissue, was then covered with Saran 
and the probe was allowed to penetrate into the muscle for 30 minutes. The filter paper 
was then removed, the muscle rinsed with a salt solution, and the animal placed on the 
microscope stage as described above. 
The excitation spectrum for Pd-MTCPP has two absorption peaks - at 410 and 523 
nm. This study employed an excitation wavelength of 525 nm, which allowed deeper 
penetration through tissue than the shorter wavelength. The emission spectrum for Pd- 
MTCPP has a wide peak ranging between 650 - 750 nm. 
Hardware and Data Acquisition 
A Zeiss Axioplan 2 microscope was configured for epi-illumination using a Zeiss 
Achroplan objective (20X, NA 0.45). A xenon flash lamp (FX-249, EG&G 
Optoelectronics, Salem, MA) with an output of 0.5 Jlflash, 3 ps duration, and a flash rate 
of 1 Hz was used to excite the probe in a region of tissue 276 pm in diameter. The light 
energy was reduced by 75% with an OD 0.6 neutral density filter (model 46214, Edmund 
Industrial Optics, Barrington, NJ), and the excitation wavelength was selected by passing 
the flash of light through a 525 nm band pass filter with a 70 nm bandwidth (Intor Inc., 
Socorro, NM). The light was then reflected through the objective and onto the tissue using 
a dichroic mirror. The resulting phosphorescence emission was collected by the objective 
and passed through the dichroic mirror and on through a 650 nrn cut-on filter (Oriel Corp., 
Stratford, CA), before detection by a photomultiplier tube. The output from the 
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photomultiplier tube was sent to an analog-to-digital converter (ADC in Fig. 3; SCB-68, 
National Instruments, Austin, TX), which was connected to a personal computer. The 
output was also monitored on an oscilloscope (model 72-3055, Tenma Test Equipment, 
Springboro, OH) in order to ensure that the maximum signal was - 8V so as not to saturate 
the analog-to-digital converter, whose maximum input was 10V. 
A customized computer program was used to acquire and process the signal from 
the analog-to-digital converter at a sampling rate of 200 kHz. 100 points were collected 
for each curve, and the curves were saved for off-line analysis (see Fig. 2.2). Each curve 
was analyzed according to the Rectangular model described above using another 
customized, automated analysis program. The high signal-to-noise ratio obtained using 
this system obviates the need to average multiple curves to obtain an accurate PISFO2 
measurement. Fig. 2.2 illustrates a representative individual phosphorescence decay curve. 
Flash Energy 
The light energy at the tissue was measured using a commercially available sensor 
(Lasercheck, Coherent, Auburn, CA). A flash rate of 100 Hz was used for this 
measurement to accon~modate the Lasercheck instrument. Power was calculated as 1.33 % 
0.01 pW. The excitation area on the tissue was 276 pm in diameter or 5.98 . lo4 cm2. 
Energy density per flash was therefore 0.22 . 10" J - ~ m - ~ .  Transillumination light was 
passed through a - 620 nm wavelength filter, which is away from the excitation spectrum 
for Pd-MTCPP. This limited excitation of the phosphorescent probe during 
transillumination, thereby minimizing light-induced production of singlet oxygen and 
endothelial cell damage. 
Figure 2.2. A representative phosphorescence decay curve. 
The smooth line indicates the fitting of the Rectangular model described in Equation 5. 
Figure 2.2 
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Volume Controlled Hemorrhage Model 
Baseline 
Once the animal platform was mounted on the microscope, ten minutes were 
allowed for equilibration, and then arterial blood gases and metabolites were obtained from 
a 95 p1 sample of blood from the carotid artery cannula. Resting diameter and red blood 
cell centerline velocity (RBC vel) were measured in the central feed arteriole, an arcade 
arteriole, and a transverse arteriole. Baseline MAP (Biopac)), HR (Biopac), and 
respiration rate (visually for 15 sec) were recorded. A central region of muscle that was at 
least 200 microns away from any microvessels greater than 20 pm in diameter was selected 
for study during the PlSF02 measurement period. PISF02 measurements were obtained once 
a second for approximately 2 minutes. 
Hemorrhage 
Blood was withdrawn from the carotid artery cannula using a New Era Pump 
Systems Inc. (Farrningdale, NY) programmable syringe pump. The hemorrhage occurred 
in three stages. In the first stage the hemorrhage rate was 0.5 mllmin for 50% of the total 
hemorrhage volume. During the second stage the hemorrhage rate was reduced to 0.25 
mVmin for 25% of the hemorrhage volume. In the final stage the hemorrhage rate was 
reduced to 0.15 mVmin for the last 25% of the hemorrhage volume. The total hemorrhage 
time was approximately 23 minutes. Measurements were recorded immediately after 
hemorrhage and then repeated 30 minutes later. 
Resuscitation 
The resuscitation began 1 hour after the conipletion of the hemorrhage. Three 
times the hemorrhage volume of Ringer solution (9gIl sodium chloride, 0.42 g/l potassium 
chloride, 0.25 g/l calcium chloride) was infused into the animal over one hour using a New 
Era Pump Systems Inc. (Farmingdale, NY) programmable syringe pump. In the 
experimental group 10 parts per million (ppm) of polyethylene glycol (MW 4500) was 
added to the Ringer solution. In other studies a concentration of 5 ppm was enough to 
drastically increase the survivability of rats during a severe hemorrhage (Kamevena, Wu et 
al. 2004; Macias, Kameneva et al. 2004). During the resuscitation period measurements 
were recorded every thirty minutes until the animal expired or for two hours. Once all 
measurements were completed, the animals were then euthanized with Euthasol(200 
mgkg i.v.). 
Statistics 
Data within these experiments are shown as mean % standard deviation in tables 
and mean * standard error in figures. One Way Analysis of Variance (ANOVA) was 
conducted with the software JMP version 6 (SAS Institute Inc., Cary NC) to asses 
statistical significance for the means of each experimental condition. Statistical 
significance between groups was determined using Student's t-test. Statistical significance 
was taken to be p < 0.05. 
Figure 2.3 Volume Controlled Hemorrhage Model Timeline. 
Where BL represents the baseline measurements; Hem represents the start of the 
hemorrhage; Hem 1 represents the measurements taken immediately after the hemorrhage 
ends and time 0; Hem 2 represents the measurements taken 30 minutes after the 
hemorrhage ends; Resusc represents the beginning of resuscitation 60 minutes after the 
hemorrhage ends; Resusc 1 represents the measurements taken 90 minutes after the 
hemorrhage ends, Resusc 2 represents the measurements taken 120 minutes after the 
hemorrhage ends and end of fluid infusion; Resusc 3 represents the measurements taken 
150 minutes after the hemorrhage ends; Resusc 4 represents the measurements taken 180 
minutes after the hemorrhage ends. 
Figure 2.3 
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Results 
Hemorrhage and Resuscitation Descriptive Data 
The rats in the Control group (N=6) weighed 268 f 18.6 grams, had a hemorrhage 
volume of 6.4 If: 0.4 ml, and a hemorrhage time of 23.6 f 1.6 minutes. The resuscitation 
volume was 19.3 f 1.3 ml with an infusion rate of 0.32 + 0.02 mumin. The rats in the 
DRP group (N=6) weighed 257 f 5.0 grams, had a hemorrhage volume of 6.2 + 0.1 ml, 
and a hemorrhage time of 22.6 f 0.4 minutes. The resuscitation volume was 18.5 + 0.4 ml 
with an infusion rate of 0.3 1 + 0.0 1 mVmin (see Table 3.1). 
Systemic Measurements 
The Control group had a MAP of 1 12 f 8 mmHg at BL. The MAP decreased to 44 
f 8 mmHg at Hem 1. At Hem 2 to the MAP increased to 61 f 14 mmHg. The MAP 
increased to 90 + 17 mmHg at Resusc 1. At Resusc 2 the MAP decreased to 88 f 20 
mmHg. The MAP decreased to 82 f 13 at Resusc 3. At Resusc 4 the MAP remained 
steady at 82 f 13 mmHg. The DRP group had a MAP of 97 f 6 mmHg at BL. The MAP 
decreased to 44 + 3 rnrnHg at Hem 1. At Hem 2 the MAP increased to 53 + 8 mmHg. The 
Table 3.1 Hemorrhage and Resuscitation Descriptive Data (k Standard deviations) 
Table 3.1 
Variables Control DRP 
Body Mass (g) 268 k 19 
Hemorrhage Volume (ml) 6.4 k 0.4 
Hemorrhage Time (min) 23.6 -+ 1.6 22.6 * 0.4 
Resuscitation Volume (ml) 19.3 k 1.3 18.5 * 0.4 
Resuscitation Rate (mVmin) 0.32 k 0.02 0.3 1 * 0.01 
3 5 
MAP increased to 90 f 16 mmHg at Resusc 1. At Resusc 2 the MAP increased to 91 f 23 
mmHg. The MAP decreased to 69 f 19 mmHg at Resusc 3. At Resusc 4 the MAP 
remained steady at 69 f 18 mrnHg (See Figure 3.1). 
The Control group had a HR of 337 f 39 bprn at BL. At Hem 1 the HR remained 
stable at 338 f 49 bpm. The HR increased to 384 f 34 bprn at Hem 2. At Resusc 1 the HR 
increased to 406 f 80 bpm. The HR increased to 426 f 21 bprn at Resusc 2. At Resusc 3 
the HR increased to 429 f 30 bpm. The HR decreased to 41 1 f 38 bprn at Resusc 4. The 
DRP group had a HR of 360 f 27 bprn at BL. The HR decreased to 336 f 50 bprn at Hem 
1. At Hem 2 the HR increased to 391 f 38 bpm. The HR increased to 433 f 40 at Resusc 
1 .At Resusc 2 the HR increased to 444 f 36 bpm. The HR increased to 457 f 34 bprn at 
Resusc 3. At Resusc 4 the HR decreased to 442 f 29 bprn (See Figure 3.2). 
The Control group had a RR of 63 f 13 breathslminute. The RR increased to 77 f 
18 breathslrninute at Hem 1, At Hem 2 the RR increased to 87 f 25 breathslminute. The 
RR increased to 90 f 26 at Resusc 1. At Resusc 2 the RR increased to 94 f 26 
breathslrninute, The RR decreased to 77 f 32 breathslminute at Resusc 3. At Resusc 4 the 
RR increased to 83 f 22 breathslrninute. The DRP group had a RR of 72 f 17 
breathslminute. The RR decreased to 65 f 21 breathslminute at Hem 1. At Hem 2 the RR 
increased to 70 k 10 breathslrninute. The RR increased to 79 f 11 breathslrninute at 
Resusc 1. At Resusc 2 the RR remained steady at 79 f 17 breathslminute. The RR 
decreased to 75 f 13 breathslrninute at Resusc 3. At Resusc 4 the RR increased to 76 f 
Figure 3.1 Mean Arterial Pressure Measurements (MAP) 
Black squares represent the Control group. Red circles represent the DRP group. Standard 
error bars are shown. * indicates significant difference from BL, t indicates significant 
difference from Hem 1, and * indicates significant difference from Hem 2 (pC0.05). 

























































Discussion 
The purpose of this study was to examine the effect of adding a minute amount of 
the DRP polyethylene glycol to a resuscitation fluid on the microcirculation of skeletal 
muscle during a volume-controlled hemorrhage model. As mentioned in the Introduction, 
prior experiments have shown positive hemodynamic effects caused by DRP's. However, 
the research on DRP's has never focused on the microcirculation during hemorrhage. In 
this experiment we were attempting to expand our knowledge by collecting data on 
arteriolar diameters, RBC velocity, and interstitial fluid POz. Heart rate, mean arterial 
pressure, respiratory rate, arterial blood gases, arterial blood electrolytes, and arterial blood 
metabolites were also measured. In this study no significant physiological differences 
were observed between the DRP group and the Control group. 
Systemic Measurements 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for MAP (See p. 37; Figure 3.1). We expected to see a positive 
difference between the DRP group and the Control group at the end of the resuscitation 
period (Kameneva, Wu et al. 2004; Macias, Kameneva et al. 2004). There was a large 
decrease in the MAP from BL to Hem 1 in both groups. A large decrease in MAP is one 
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of the main signs of acute hemorrhage (Berne and Levy 2004; Costanzo 2006). At Hem 2 
MAP for both groups began an increasing trend. The increasing trend in MAP before 
resuscitation indicates that the compensatory mechanisms were working. From Hem 2 the 
Control group MAP increased peaking at 90 * 17 mmHg at Hem 1. The MAP decreased 
slightly from Resusc 1 to Resusc 3 where it remained steady through Resusc 4. In the 
Control group there was a statistically significant difference between Resusc 1-4 and BL, 
Heml, and Hem 2. In the DRP group the MAP increased enough by Resusc 1 that there 
was no statistically significant difference with BL. The MAP peaked at 91 * 3 mmHg at 
Resusc 2. There was a decrease fiom Resusc 2 to 69 * 19 mmHg at Resusc 3 where it 
remained steady through Resusc 4. In the DRP group there was a statistically significant 
difference between Resusc 1-4 and Hem 1 ; Resusc 1-2 and Hem 2; and Resusc 3-4 and 
BL. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for HR (See p. 39; Figure 3.2). Within the groups there was no 
statistically significant difference between BL and Hem 1 and BL and Hem 2 for HR. 
However, the mean HR exhibited an upward trend by Hem 2 in both groups. Tachycardia 
is the normal compensatory response to an acute hemorrhage (Berne and Levy 2004; 
Costanzo 2006) However, it has been shown that an absence of the tachycardic response is 
not uncommon (Thomas and Dixon 2004). In the DRP group there was a statistically 
significant difference between Hem 1 and Hem 2. The HR increased from 336 A 50 bpm 
at Hem 1 to 391 * 38 at Hem 2. In both groups the mean HR had an increasing trend until 
Resusc 3 and then a small decreasing trend at Resusc 4. There was a statistically 
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significant difference between Resusc 1-4 and BL and Resusc 1-4 and Hem 1 in both 
groups. In the context of time points for different variables, Resusc 1-4 means Resusc 1,2, 
3 and 4 are considered individually. A similar meaning is intended for Resusc 2-4, etc. 
The DRP group also had a statistically significant difference between Hem 2 and Resusc 2- 
4. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for RR (See p. 42; Figure 3.3). There were large standard deviations 
in the RR measurements in both groups. This may be attributed to the animals' varying 
response to the anesthetic. In the Control group the RR exhibited an increasing trend from 
BL to Resusc 2. There was a decreasing trend in RR at Resusc 3 with a slight increasing 
trend between Resusc 3 and Resusc 4. There was a statistically significant difference in 
RR between BL and Hem 2, and BL and Resusc 1-2. In the DRP group there was a slight 
decreasing trend from BL to Hem 1. From Hem 1 to Resusc 1 there was an increasing 
trend. The RR remained relatively steady between Resusc 1 through Resusc 4. There was 
no statistically significant difference between any RR measurements within the DRP 
group- 
Microvascular Measurements 
Arteriole Diameters 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Feed diameter (See p.44; Figure 3.4). The Feed diameter 
exhibited a decreasing trend from BL to Hem 1 in both groups. The reduction in MAP 
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during hemorrhage decreases the stimulation of the baroreceptors in the carotid sinuses and 
aortic arch. Generalized arteriolar constriction is a prominent response to diminished 
baroreceptor stimulation during hemorrhage (Berne and Levy 2004; Costanzo 2006). In the 
Control group the Feed diameter continued a decreasing trend to Resusc 1. There was a 
slight increasing trend in the Feed diameter f'rom Resusc 1 to Resusc 2. There was a 
decreasing trend in the Feed diameter from Resusc 2 to Resusc 3 and a small increasing 
trend from Resusc 3 to Resusc 4. There was a statistically significant difference between 
Resusc 1-4 and BL in the Control group. In .the DRP group the Feed diameter exhibited a 
decreasing trend between Hem 1 and Hem 2. The Feed diameter continued a decreasing 
trend from Hem 1 to Resusc 1. There was an increasing trend in the Feed diameter 
between Resusc 1 and Resusc 2. There was a decreasing trend in the Feed diameter from 
Resusc 2 to Resusc 3 and an increasing trend from Resusc 3 to Resusc 4. There was a 
statistically significant difference between Resusc 1 and BL and Resusc 3 and BL in the 
DRP group. 
There was a statistically significant difference between the DRP group and the 
Control group at BL, Hem 1 and Resusc 4 (See p. 47; Figure 3.5). The DRP measurements 
may have been made more proximal to the Feed arteriole. This would account for the 
larger BL values. At BL the Control group had an Arcade diameter of 28 h 8 pm and the 
DRP group had an Arcade diameter of 43 h 15 pm. At Hem 1 the Control group had an 
Arcade diameter of 3 1 * 10 pm and the DRP group had an Arcade diameter of 45 * 14 
pm. At Resusc 4 for the Control group had an Arcade diameter of 21 h 2 pm and the DRP 
had an Arcade diameter of 39 h 13 pm. There was an increasing trend in Arcade diameter 
from BL to Hem 2 in both groups. Both groups also exhibited a decreasing trend in 
Arcade diameter from Hem 2 to Resusc 1. In the Control group the Arcade diameter 
remained steady from Resusc 1 to Resusc 2 and then exhibited a decreasing trend to 
Resusc 4. There was no statistically significant difference between any Arcade diameter 
measurements within the Control group. In the DRP group the Arcade diameter exhibited 
a small decreasing trend from Resusc 1 to Resusc 3. There was an increasing trend in 
Arcade diameter from Resusc 3 to Resusc 4. There was no statistically significant 
difference between any Arcade diameter measurements within the DRP group. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Transverse diameter (See p. 49; Figure 3.6). There was an 
increasing trend in the Transverse diameter from BL to Hem 2 in both groups. From Hem 
2 the Transverse diameter exhibited a decreasing trend in both groups to Resusc 1. In the 
Control group the Transverse diameter continued a decreasing trend to Resusc 2. There 
was a statistically significant difference between Resusc 2 and BL in the Control group. 
The Transverse diameter exhibited an increasing trend from Resusc 2 to Resusc 3. In the 
DRP group the Transverse diameter exhibited an increasing trend from Resusc 1 to Resusc 
3. There was no statistically significant difference between any Transverse diameter 
measurements within the DRP group. The Transverse diameter exhibited a decreasing 
trend between Resusc 3 and Resusc 4 in both groups. 
Red Blood Cell Velocity and Flow 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Feed RBC vel (See p. 52; Figure 3.7). We expected to see a 
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positive difference between the DRP group and the Control group based upon prior in vitro 
research (See Figure 1 Kameneva Wu et al. 2004). There was a decrease in the RBC vel 
between BL and Hem 2 in both groups. A decrease in MAP would cause a decrease in 
dnving pressure and a subsequent decrease in RBC vel. Both groups had a statistically 
significant difference between Hem 2 and BL. In both groups the RBC vel exhibited an 
increasing trend between Hem 2 and Resusc 2. However, there remained a statistically 
significant difference between Resusc 2 and BL in the DRP group. We expected the DRP 
group to have a higher RBC vel than the Control group (Kameneva, Wu et al. 2004). 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Feed Arteriole blood flow (See p. 54; Figure 3.8). There was a 
decrease in blood flow between BL and Hem 2 in both groups. Again, the decrease in the 
MAP causes a decrease in driving pressure, which decreases flow. There was a small 
increasing trend in flow between Hem 2 and Resusc 2. There was a statistically significant 
difference between BL and Hem 2 and BL and Resusc 2 in both groups. 
Interstitial Fluid PO2 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for PISF02 (See p. 56; Figure 3.9). We expected to see a positive 
difference between the DRP and the Control group during the resuscitation period 
(Kameneva, Wu et al. 2004). Kameneva, Wu et al. showed a significant difference 
between DRP and Control groups for transcutaneous tissue perfusion after resuscitation 
(Kameneva, Wu et al. 2004). There was a decrease in PlSF02 from BL to Hem 2 in both 
groups. A decrease in 0 2  transport is one of the major pathological conditions associated 
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with hemorrhage. As expected a decrease in flow directly correlated with a drop in 
Interstitial Fluid PO2. The resuscitation did initially help increase the PI SF^^, but then it 
dropped back down to hemorrhage values. There was an increasing trend in PlSF02 
between Hem 2 and Resusc 1 in both groups. Both had a decreasing trend in PISF02 from 
Resusc 1 to Resusc 2. In the Control group the PIsF02 remained steady through Resusc 3 
and exhibited an increasing trend between Resusc 3 and Resusc 4. In the DRP group the 
P1S~02  continued a decreasing trend to Resusc 3. There was an increasing trend between 
Resusc 3 and Resusc 4. There was a statistically significant difference between BL and 
Hem 1, Hem 2, and Resusc 1-4 in both groups. 
Arterial Blood Measurements 
Gas 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial PO2 (See p. 59; Figure 3.10). There was an increasing 
trend in PO2 from BL to Hem 1 and a small continued increasing trend between Hem 1 and 
Hem 2 for both groups. An increase in PO2 is an expected response to an acute 
hemorrhage due to hyperventilation (Macias, Kameneva et al. 2004; Torres, Tones Filho et 
al. 2004). Both groups had a decrease in PO2 between Hem 2 and Resusc 1. There was a 
statistically significant difference in PO2 between Hem 2 and Resusc 1 in both groups. 
The PO2 exhibited an increasing trend between Resusc 1 and Resusc 2 and then a 
decreasing trend between Resusc 2 and Resusc 4 in both groups. 
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Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial PC02 (See p. 61; Figure 3.1 1). There was a sharp 
decreasing trend in PC02 between BL and Hem 1 and a continued decreasing trend in 
PC02 between Hem 1 and Hem 2 in both groups. A decrease in PC02 is a common 
hyperventilatory response to an acute hemorrhage (Macias, Karneneva et al. 2004; Torres, 
Torres Filho et al. 2004). There was a statistically significant difference in PC02 between 
Hem 2 and BL in both groups. In both groups the PC02 exhibited an increasing trend from 
Hem 2 to Resusc 1. In the Control group the PC02 exhibited a decreasing trend from 
Resusc 1 to Resusc 2. The PO2 remained steady between Resusc 2 and Resusc 3. There 
was a small increasing trend in PO2 from Resusc 3 to Resusc 4. In the DRP group there 
was a continued increasing trend in PO2 until Resusc 2. Between Resusc 2 and Resusc 3 
there was a small decreasing trend in PO2. The decreasing trend in PO2 continued between 
Resusc 3 and Resusc 4. 
Oxygenation 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial SO2 (See p. 64; Figure 3.12). The mean SO2 never fell 
below 94 k 4 % and 93 k 3 % for the Control group and DRP group respectively. 
Therefore, the miniscule changes in the SO2 would not have a physiological effect on the 
other variables. However, there was a statistically significant difference between Hem 2 
and Resusc 1 in the DRP group. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial 02ct (See p. 66; Figure 3.13). There was a statistically 
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significant decrease in 02ct from BL to Hem 1 in both groups due. A decrease in 02ct is 
an expected response to an acute hemorrhage to absorption of interstitial fluid into the 
intravascular space (Vladeck, Bassin et al. 1971; Torres, Torres Filho et al. 2004). In the 
Control group there is a small increasing trend in 02ct from Hem 1 to Hem 2. In the DRP 
group there is a small decreasing trend in 02ct from Hem 1 to Hem 2. There is a 
decreasing trend in 02ct from Hem 2 to Resusc 2 in both groups. This is an expected 
consequence of hemodilution (Gutierrez et al. 2004). The Ozct exhibited an increasing 
trend from Resusc 2 through Resusc 4 in both groups. There is a statistically significant 
difference between BL and Heml, Hem 2, and Resusc 1-4 in both groups. There is a 
statistically significant difference between Hem 1 and Resusc 1-4 and Hem 2 and Resusc 
1-4 in both groups. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial [Hb] (See p. 69; Figure 3.14). The Arterial [Hb] 
followed the same trend as the Arterial 02ct and Hct. There was a decrease in [Hb] from 
BL to Hem 1 in both groups. In the Control group there is a small increasing trend in [Hb] 
from Hem 1 to Hem 2. In the DRP group there is a small decreasing trend in [Hb] from 
Hem 1 to Hem 2. There is a decrease in [Hb] from Hem 2 to Resusc 2 in both groups due 
to hemodilution (Gutierrez, Reines et al. 2004; Macias, Kameneva et al. 2004). The [Hb] 
exhibited an increasing trend from Resusc 2 through Resusc 4 in both groups. There is a 
statistically significant difference between BL and Heml, Hem 2, and Resusc 1-4 in both 
groups. There is a statistically significant difference between Hem 1 and Resusc 1-4 and 
Hem 2 and Resusc 1-4 in both groups. 
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Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial Hct (See p. 7 1 ; Figure 3.15). There was a statistically 
significant decrease from BL to Hem 2 in both groups. The hemodilution caused by 
resuscitation decreased the Hct in both groups. In the Control group there was a 
statistically significant decrease from Hem 2 to Resusc 1 and then a small decrease from 
Resusc 1 to Resusc 2. In the DRP group there was a decrease from Hem 2 through Resusc 
1 to Resusc 2. There was a statistically significant difference between Hem 2 and Resusc 
Energy Metabolites 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial Plasma Glucose Concentration (Glu) (See p. 74; Figure 
3.16). There was a statistically significant increase in Glu from BL to Hem 1 in both 
groups. This is an expected response to an acute hemorrhage (Macias, Kanieneva et al. 
2004; Torres, Torres Filho et al. 2004). There was a small decreasing trend in Glu in both 
groups from Hem 1 to Hem 2. In the Control group Hem 2 was still significantly different 
than BL. There was a statistically significant decrease in Glu between Hem 2 and Resusc 
1 in both groups. The Glu continued a decreasing trend from Resusc 1 to Resusc 3 in both 
groups. There was a small increasing trend in Glu between Resusc 3 and Resusc 4 in both 
groups. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial Plasma Lactate Concentration (Lac) (See p. 76; Figure 
3.17). We expected the DRP group to have a lower Lac than the Control group during the 
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resuscitation period (Kameneva, Wu et al. 2004). There was a statistically significant 
increase in Lac from BL to Hem 1 in both groups. The decreased oxygen delivery to the 
cells accelerates the production of lactic acid (Berne and Levy 2004; Costanzo 2006). 
There was a small decreasing trend in Lac in both groups from Hem 1 to Hem 2. There 
was a statistically significant decrease in Lac between Hem 2 and Resusc 1 in both groups. 
However, both groups still had a statistically significant difference between Resusc 1 and 
BL. Both groups continued a decreasing trend toward BL until Resusc 2 and then 
exhibited an increasing trend at Resusc 3. There was a statistically significant difference 
between Resusc 3 and BL in the DRP group. The Control group had a small decreasing 
trend between Resusc 3 and Resusc 4. In the DRP group there was a very small increasing 
trend between Resusc 3 and Resusc 4. 
Acid5ase Metabolites and pH 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial Base Excess (See p. 79; Figure 3.18). There was a 
statistically significant decrease in BE from BL to Hem 1 in both groups. In both groups 
BE continued a decreasing trend from Hem 1 to Hem 2. A decrease in BE is an expected 
response to an acute hemorrhage (Torres, Torres Filho et al. 2004). Then there was an 
increasing trend from Hem 2 to Resusc 1 in both groups. In the Control group the BE 
remained steady to Resusc 2. There was a small decreasing trend between Resusc 2 and 
Resusc 3 and an increasing trend between Resusc 3 and Resusc 4. There was a statistically 
significant difference between BL and Heml, Hem 2, and Resusc 3 in the Control group. 
In the DRP group the BE exhibited an increasing trend from Resuscl to Resusc 2. Then 
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there was a decreasing trend from Resusc 2 to Resusc 4. There was a statistically 
significant difference between BL and Heml, Hem 2, Resusc 1, Resusc 3, and Resusc 4 in 
the DRP group. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial HC03- (See p. 8 1 ; Figure 3.19). There was a 
statistically significant decrease in HC03- from BL to Hem 1 in both groups. A decrease 
in HC03- is a common response to hemorrhage in order to preserve acid-base balance 
(Torres, Torres Filho et al. 2004). In the Control group the HC03- exhibited an increasing 
trend from Hem 1 to Hem 2, which continued through Resusc 1 to Resusc 2. There was a 
decreasing trend from Resusc 2 to Resusc 3 and an increasing trend from Resusc 3 to 
Resusc 4. There was a statistically significant difference between BL and Heml, Hem 2, 
and Resusc 3 in the Control group. In the DRP group the HC03- exhibited a decreasing 
trend from Hem 1 to Hem 2. Then there was an increasing trend from Hem 2 to Resusc 2 
and a decreasing trend from Resusc 2 to Resusc 3 where the HC03- remained steady 
through Resusc 4. There was a statistically significant difference between BL and Heml, 
Hem 2, Resusc 1, and Resusc 3 in the DRP group. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial pH (See p. 83; Figure 3.20). We would have expected 
the DRP group to have a higher pH than the Control group during the end of the 
resuscitation period (Kameneva, Wu et al. 2004). There was a decreasing trend in pH from 
BL to Hem 1 and an increasing trend from Hem 1 to Hem 2 in both groups. Both groups 
had a decreasing trend between Hem 2 and Resusc 1 and an increasing between Resusc 1 
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and Resusc 2. In the Control group the pH exhibited a decreasing trend between Resusc 2 
and Resus 3 and an increasing trend between Resusc 3 and Resusc 4. In the DRP group 
the pH remained the same between Resusc 2 and Resusc 3. There was a small increasing 
trend between Resusc 3 and Resusc 4. There was no statistically significant difference 
within both groups. 
Electrolytes 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial Na+ (See p. 86; Figure 3.21). There was a statistically 
significant decrease in ~ a +  from BL to Hem 1 and an increasing trend from Hem 1 to Hem 
2 in both groups. Both groups had a statistically significant increase between Hem 2 and 
Resusc 1. In the Control group the Na+ remained the same from Resusc 1 to Resusc 2 and 
exhibited an increasing trend between Resusc 2 and Resusc 4. There was a statistically 
significant difference between BL and Hem 1, Hem 2, and Resusc 2-4 in the Control 
group. In the DRP group the Na+ continued an increasing trend between Resusc 1 and 
Resusc 2. There was a decreasing trend between Resusc2 and Resusc 4. There was a 
statistically significant difference between BL and Hem 1 and Resusc 1-4 in the DRP 
group- 
There was a statistically significant difference the Control group and the DRP 
group at Hem 1 for Arterial K+ (See p. 88; Figure 3.22). Both groups exhibited an 
increasing trend from BL to Hem 1. The Control group K+ was 4.5 * 0.7 meq/L at Hem 1. 
The DRP group K+ was 5.95 * 0.8 meq/L at Hem 1.  In the Control group there was a 
small increasing trend from Hem 1 to Hem 2 and a small decreasing trend between Hem 2 
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and Resusc 1. There was an increasing trend between Resusc 1 and Resusc 2 and a 
decreasing trend between Resusc 2 and Resusc 4. There was a statistically significant 
difference between BL and Resusc 2 in the Control group. In the DRP group there was a 
decreasing trend from Hem 1 to Resusc 1 and an increasing trend between Resusc 1 and 
Resusc 3. There was a small decreasing trend between Resusc 3 and Resusc 4. There was 
a statistically significant difference between BL and Hem 1, Hem 2, and Resusc 2-4 in the 
DRP group. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial Cl- (See p. 91; Figure 3.23). There was no statistically 
significant difference within both groups. The Control group exhibited a small increasing 
trend from BL to Hem 2 and then a decreasing trend to Resusc 1. There was a small 
increasing trend between Resusc 1 and Resusc 2 and a continued increasing trend between 
Resusc 2 and Resusc 3. There was a decreasing trend between Resusc 3 and Resusc 4. In 
the DRP group there was a small decreasing trend from BL to Hem 2. There was an 
increasing trend between Hem 2 and Resusc 3. There was a decreasing trend between 
Resusc 3 and Resusc 4. 
Overall, there was no statistically significant difference between the DRP group 
and the Control group for Arterial ca2+ (See p. 93; Figure 3.24). There was an increasing 
trend from BL to Hem 1 in both groups. In the Control group the ca2+ remained the same 
at Hem 2. There was an increasing trend between Hem 2 and Resusc 2 and then a 
decreasing trend from Resusc 2 to Resusc 3. The ca2+ remained the steady at Resusc 4. 
There was a statistically significant difference between BL and Resusc 1-4 and between 
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Hem 2 and Resusc 2 in the Control group. In .the DRP group there was a decreasing trend 
between Hem 1 and Hem 2 and an increasing trend between Hem 2 and Resusc 1. The 
ca2+ remained steady at Resusc 2, exhibited a decreasing trend at Resusc 3, and remained 
steady through Resusc 4. 
Conclusion 
Adding a minute amount of the DRP polyethylene glycol to a resuscitation fluid 
during hemorrhagic shock resuscitation did not affect the skeletal muscle microcirculation. 
The unexpected finding in this study was that there were no significant physiological 
differences between the DRP group and the Control group interpreted from the data 
collected. 
There are a few plausible explanations as to why we did not see any differences 
between the DRP and the Control group. The hemorrhage protocol for our experiment was 
drastically different than other hemorrhage studies with DRP's. Our animals were not 
resuscitated for 1 hour after hemorrhage compared to 5 minutes in other DRP experiments. 
Also, we infused fluid for one hour during resuscitation compared to the entire duration of 
the resuscitation in other DRP experiments. The protocol we used has more clinical 
relevance than the other DRP hemorrhage experiments. Due to the natural standard 
deviation of certain variables and the small degree of change between conditions and 
groups; a sample size of six animals was too small to show a significant difference. 
Recommendations for Future Studies 
Although, our protocol has more clinical relevance I would recommend following 
the hemorrhage protocol used during successful DRP experiments. If there are positive 
results when using the other protocol then try the volume controlled hemorrhage protocol 
again. In order to show a significant difference between conditions and groups, a large 
enough sample size should be used to account for the natural standard deviation of certain 
variables. A power analysis of the different variables should be done to find the right 
sample size. 
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APPENDIX 1 
Raw Data 
Units of Measurement 
MAP, PO2, PC02, and PISFO2 measured in mrnHg 
Artertiolar Diameters measured in pm 
HR measured in beats per minute 
RR measured in respirations per minute 
Feed Arteriole Average Luminal RBC vel measured in mrnlsec 
Feed Arteriole Blood Flow measured in pllsecond 
Arterial Blood SO2 measured in percent saturation 
Arterial Blood 0 2  Content measured in volume percent 
Arterial Blood Hemoglobin Concentration measured in gldl 
Arterial Blood Hematocrit measured in percent of whole blood 
Arterial Plasma Glucose Concentration measured in mgldl 
Arterial Plasma Lactate Concentration, Base Excess, and HC03- measured in rnmol1L 
Arterial Blood Electrolytes ~ a ' ,  K', C1-, and ca2+ measured in meq/L 
***** represents technical errors 
xxxxx represents a deceased animal 
CONTROL 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
2 
1.1 
7.8 
7.2 
6.2 
6 
XXXXX 
2 
98 
332 
146 
69 
42 
XXXXX 
XXXXX 
2 
2.3 
4.8 
4.5 
5.3 
6.4 
XXXXX 
XXXXX 
2 
122 
105 
124 
122 
138 
XXXXX 
XXXXX 
Lactate 
4 5 
1.2 0.9 
7.2 6.2 
5.7 6.7 
1.2 2.3 
0.9 1.5 
1.5 1.5 
2.3 3 
Glucose 
4 5 
174 131 
376 379 
274 391 
156 227 
149 174 
153 146 
142 141 
XXXXX 
6 
1 64 
506 
615 
354 
239 
64 
XXXXX 
Potassium 
4 5 6 
4.4 3.5 4.2 
5.3 3.5 5 
5 4.4 5.6 
4.7 3.8 5.7 
4.6 4.1 5.5 
4.6 4.1 7.2 
4.9 4.2 xxxxx 
6 
100 
134 
140 
104 
117 
126 
XXXXX 
AVG 
0.966667 
7.883333 
7.18 
3.733333 
3.3 
3.74 
3.25 
AVG 
133.6667 
427.1667 
390.3333 
207.5 
152.3333 
1 18.4 
127 
AVG 
3.4 
4.5 
4.666667 
4.566667 
4.783333 
4.68 
4.5 
AVG 
105.3833 
114.7167 
118.7167 
99.48333 
109.3 
108.02 
99.75 
STD 
0.350238 
1.895697 
1.958826 
3.467948 
2.804461 
3.941 193 
1.201388 
STD 
34.56395 
96.43737 
205.5594 
112.5784 
70.13891 
46.26338 
22.55364 
STD 
0.944458 
0.657267 
0.557375 
0.804156 
0.982683 
1.502332 
0.408248 . 
STD 
16.60318 
14.53278 
17.72799 
15.84126 
20.46851 
17.73702 
7.751774 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
1 2 
46.9 20.6 
31.4 26.4 
22.3 15.3 
27.1 2 1 
20.6 17.1 
16.1 xxxxx 
23.7 xxxxx 
1 2 
89.5 98.4 
94.1 95.1 
98.8 97.1 
97.3 97.1 
99.3 97.8 
99 XXXXX 
99.9 XXXXX 
1 2 
140 146 
138 136 
138 148 
147 149 
147 138 
143 xxxxx 
148 xxxxx 
1 2 
119 ***** 
120 ***** 
125 ***** 
142 ***** 
143 ***** 
133 xxxxx 
133 xxxxx 
PC02 
4 5 
41.1 31.3 
27.1 30.9 
25.5 31.3 
32.8 32.3 
30.9 33.2 
27.8 31 
24.1 28.7 
so2 
4 5 
91 95.2 
94.1 94.4 
96.4 92.7 
88.1 92.3 
90.7 91.3 
94.1 94.2 
94.9 95.5 
Sodium 
4 5 
143 146 
140 141 
143 141 
150 149 
153 152 
152 151 
157 151 
Chloride 
4 5 
64 60 
115 62 
98 78 
3 1 8 8 
5 1 98 
80 119 
63 58 
6 
52.2 
24.7 
19.6 
23 
21.7 
21.5 
xxxxx 
6 
92.7 
98.2 
97.3 
91.3 
95.6 
92.8 
xxxxx 
6 
144 
138 
136 
152 
158 
160 
xxxxx 
6 
162 
5 5 
20 1 
120 
4 1 
196 
xxxxx 
AVG 
36.35 
27.8 
22.71667 
27.45 
24.9 1667 
25.12 
27.025 
AVG 
93.76667 
95.63333 
96.9 
93.91667 
95.41667 
95.2 
95.975 
AVG 
145.8333 
138.6667 
140.5 
150 
150.3333 
152.6 
153.75 
AVG 
101.25 
11 1.4 
119 
88.8 
92 
132.8 
93 
STD 
12.37558 
2.715879 
5.412732 
4.79 1 138 
6.255691 
6.18199 
3.801206 
STD 
3.306156 
1.909625 
2.30391 
3.924496 
3.62404 
2.392697 
2.734197 
STD 
5.455884 
1.75119 
4.505552 
2.19089 
7.00476 
6.503845 
5.123475 
STD 
48.63041 
60.14399 
48.8825 1 
44.18937 
45.12206 
41.78157 
38.07887 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
2 
1.62 
2.03 
2.03 
2.18 
2.23 
XXXXX 
xxxxx 
2 
-1 1.5 
-15.7 
-17.5 
-15.2 
-17.3 
xxxxx 
xxxxx 
2 
16.7 
12.9 
12.6 
13.7 
12.5 
XXXXX 
xxxxx 
2 
7.399 
7.223 
7.328 
7.301 
7.299 
xxxxx 
xxxxx 
Calcium 
4 5 
2.43 2.15 
2.62 2.21 
2.5 2.16 
2.55 2.39 
2.6 2.64 
2.5 2.53 
2.47 2.48 
Base(Ec8 
4 5 
-2 -3.1 
-10.1 -9.5 
-8.3 -9.6 
-4 -6.5 
-5.6 -4.9 
-5.8 -4.4 
-7.6 -5.8 
Bicarbonate 
4 5 
-22.6 22.5 
17 17.3 
18.7 17.1 
21.5 19.5 
20.4 20.8 
20.6 21.4 
19.4 20.5 
PH 
4 5 
7.36 7.432 
7.343 7.319 
7.403 7.312 
7.4 7.363 
7.393 7.383 
7.424 7.413 
7.433 7.412 
6 
2.48 
2.59 
2.3 
2.68 
2.8 
2.86 
xxxxx 
6 
0.3 
-13.8 
-16.8 
-17.7 
-15.9 
-21.2 
xxxxx 
6 
23.7 
14.5 
12.7 
11.7 
13.2 
9.3 
xxxxx 
6 
7.315 
7.292 
7.278 
7.207 
7.274 
7.111 
xxxxx 
AVG 
2.173333 
2.34 
2.265 
2.42 
2.565 
2.5 1 
2.4575 
AVG 
-5.1 1667 
-1 1.9 
- 12.2667 
-9.76667 
-9.81667 
-10.94 
-8.85 
AVG 
20.5 
15.63333 
15.9 
17.43333 
17.66667 
16.82 
18.175 
AVG 
7.355667 
7.298 
7.351 167 
7.3415 
7.373667 
7.3404 
7.3735 
STD 
0.328309 
0.227 156 
0.160219 
0.176182 
0.270758 
0.2841 65 
0.140327 
STD 
5.229308 
2.568268 
3.923604 
5.400988 
5.387176 
6.702089 
2.69 1344 
STD 
3.3651 15 
1.865118 
2.6222 13 
3.82761 9 
3.769173 
4.813211 
2.251481 
STD 
0.050792 
0.05622 1 
0.053402 
0.075386 
0.075 104 
0.135659 
0.076675 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 1 
Baseline: 336 
Hem 1 340 
Hem 2 374 
Resusc 1 276 
Resusc 2 4 17 
Resusc 3 436 
Resusc 4 415 
2 
104 
33 
43 
67 
62 
xxxxx 
xxxxx 
2 
341 
368 
397 
407 
430 
xxxxx 
xxxxx 
Experiment: 1 2 
Baseline: 72 80 
Hem 1 104 8 0 
Hem 2 92 116 
Resusc 1 96 120 
Resusc 2 108 136 
Resusc 3 116 xxxxx 
Resusc 4 108 xxxxx 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
1 
site 1 
42.46 
2.14 
0.77 
0 
0.91 
0 
0 
MAP 
3 4 5 
123 118 114 
47 40 46 
83 59 63 
114 82 92 
112 89 99 
69 90 96 
78 85 98 XXXXX 
XXXXX 
RR 
3 - 4  5 6 
44 68 60 5 2 
76 88 60 5 6 
104 91 48 68 
116 84 56 68 
96 88 60 76 
88 91 60 3 2 
80 88 56 xxxxx 
1 
site 2 
64.87 
1.53 
0.44 
0.71 
0.68 
0 
0 
PI SF^ 
2 
site 1 
47.6 
1.67 
0.3 1 
0.36 
1.37 
xxxxx 
XXXXX 
AVG 
112.3333 
43.8 
6 1 
90 
87.58 
8 1.85 
82.225 
AVG 
337.1667 
337.8 
384.2 
406.4 
425.6 
428.5 
41 1.25 
AVG 
62.66667 
77.33333 
86.5 
90 
94 
77.4 
83 
STD 
8.066391 
7.596052 
14.42221 
17.30607 
19.49056 
13.17915 
12.64394 
STD 
38.60786 
48.489 17 
33.46939 
80.03937 
20.98333 
30.04996 
38.26552 
STD 
13.30664 
17.82882 
24.70425 
25.64371 
26.38181 
32.2149 
2 1.50969 
2 
site 2 
57.9 
1.66 
0.17 
0.63 
0.92 
xxxxx 
XXXXX 
3 
site 1 
66.61 
4.2 
33.33 
46.44 
3 1.3 
26.33 
32.28 
3 
site 2 
69.66 
48.3 
36.01 
46.5 
57.72 
32.2 1 
30.04 
Experiment: 4 
site 1 
73.94 
75.01 
74.42 
77.79 
58.55 
60.7 
46.75 
4 
site 2 
76.41 
50.53 
50.77 
40.09 
40.16 
34.53 
35.83 
5 
site 1 
79.05 
58.49 
51.31 
7 1.49 
60.07 
57.12 
38.38 
5 
site 2 
73.95 
37.3 1 
43.69 
55.34 
44.16 
36.06 
30.03 
6 
site 1 
62.44 
50.49 
0.68 
24.429 
0 
0 
XXXXX 
6 
site 2 
67.83 
3 1.46 
1.08 
30.91 
1.07 
0 
XXXXX 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
AVG 
65.22667 
30.2325 
24.4 15 
32.89075 
24.7425 
24.695 
26.66375 
STD 
1 1.22946 
26.84436 
26.8235 
28.15924 
26.2325 1 
23.73968 
17.32435 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Hct 
3 4 5 6 
37 3 6 35.2 40.4 
27.7 28 25.5 ***** 
21 22 18.7 ***** 
22 2 1 16.3 ***** 
Experiment: 1 
Baseline: ***** 
Hem 2 29 
Resusc 1 15.9 
Resusc 2 16.4 
AVG STD SE 
36.92 2.0474 0.916 
28.04 1.683 0.753 
19.32 2.355 1.053 
18.94 2.5996 1.163 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
AVG 
12.62 
9.1 17 
9.533 
6.717 
6.417 
6.82 
6.9 
STD 
0.61 1 
0.697 
0.717 
1.026 
1.087 
0.589 
1.010 
2 
16 
11.1 
13.7 
9.7 
8.1 
XXXXX 
xxxxx 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
6 
16.8 
14.1 
11.5 
7.7 
7.5 
8.1 
XXXXX 
AVG 
16.1 
11.92 
12.72 
8.58 
8.28 
8.8 
9 
STD 
0.710 
1.144 
0.873 
1.311 
1.353 
0.685 
1.175 
RBC Velocity 
Experiment: 1 2 3 4 5 6 AVG STD SE 
Baseline: 18.3 26 26.06 ***** 24.875 22.48125 23.54 3.270 1.462 
Hem 2 4.35 3.9375 16.98 ***** 16.125 ***** 10.35 7.175 3.588 
Resusc 2 12.09 1.25 27.26 ***** 25.825 ***** 16.61 12.31 6.156 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
1 2 
23.5 26.4 
26 45 
32.3 40.8 
28.7 37.1 
23.6 38.6 
22.5 xxxxx 
23.6 xxxxx 
Experiment: 1 l b  
Baseline: 15.5 17.6 
Hem 1 25.6 22 
Hem 2 25.1 26 
Resusc 1 23.9 22 
Resusc 2 20.3 19.6 
Resusc 3 20.6 20 
Resusc 4 15.2 21.8 
Experiment: 1 
Baseline: 53.9 
Hem 1 44.2 
Hem 2 41.1 
Resusc 1 27.3 
Resusc 2 36.6 
Resusc 3 32.7 
Resusc 4 35.5 
2 
15.6 
16.4 
14.3 
16.6 
14.1 
XXXXX 
xxxxx 
2 3 
55.6 50.3 
59.4 40.5 
48.9 32.4 
57.2 36.5 
55.9 31.2 
xxxxx 33.8 
xxxxx 35.1 
Arcade Diameter 
4 5 6 
***** 23 25.8 
***** 17.7 29.2 
***** 19.7 ***** 
***** 20.2 ***** 
***** 19.9 ***** 
***** 19.9 xxxxx 
***** 19.2 xxxxx 
Transverse Diameter 
3 4 5 6 
13.7 ***** 14.9 19.9 
15.2 ***** 14.8 25.3 
25.8 ***** 11.8 ***** 
11 ***** 10.3 ***** 
7.5 ***** 11 ***** 
15.4 ***** 11 xxxxx 
16.6 ***** 10.3 xxxxx 
Feed Diameter 
4 5 5b 
***** 48 53.3 
***** 38.4 49 
***** 36.3 51 
***** 33.7 41.2 
***** 31.8 41.6 
***** 32.7 42.8 
***** 31.6 44.3 
XXXXX 
xxxxx 
Flow 
Diameter Velocity Flow 
(pm) (mmls) (cm2/s) 
BL 
0.00539 2.928 4.18E-05 
0.00556 4.16 6.3 1E-05 
0.00503 4.17 5.18E-05 
0.0048 3.98 4.5E-05 
0.00574 3.597 5.82E-05 
AVG 
27.96 
30.64 
35.025 
27.075 
27.175 
24.333 
2 1 
AVG 
16.2 
19.883 
20.6 
16.76 
14.5 
16.75 
15.975 
AVG 
53.083 
47.333 
41.94 
39.18 
39.42 
35.5 
36.625 
STD 
7.488 
10.234 
11.921 
7.598 
8.095 
5.581 
2.307 
STD 
2.21 1 
5.028 
6.957 
6.192 
5.501 
4.482 
4.730 
STD SE 
3.443 1.406 
7.892 3.222 
7.970 3.564 
11.260 5.036 
10.123 4.527 
4.894 2.447 
5.408 2.704 
Conversion: 
ml+microliters 
BL AVG STD SE 
0.041756 0.05 1972 0.008884 0.003973 
0.063 127 
0.05 179 
0.045013 
0.058175 
HEM2 0.010964 0.004782 0.002391 
0.005771 
0.007395 
0.014001 
0.016688 
RESUSC2 0.014285 0.008368 0.0041 84 
0.012717 
0.003068 
0.020843 
0.0205 1 1 
Experiment: 1 
Baseline: 1.6 
Hem 1 7.4 
Hem 2 6.8 
Resusc 1 3.9 
Resusc 2 2.8 
Resusc 3 2.6 
Resusc 4 3.6 
7.3 
10.4 
XXXXX 
Experiment: 1 2 
Baseline: 179 220 
Hem 1 421 147 
Hem 2 48 1 89 
Resusc 1 243 69 
Resusc 2 142 45 
Resusc 3 119 10 
Resusc 4 132 xxxxx 
Experiment: 1 2 
Baseline: 3.3 4 
Hem 1 6.1 5.8 
Hem 2 5 6.4 
Resusc 1 4.2 5.9 
Resusc 2 4.8 7.3 
Resusc 3 4.9 9.4 
Resusc 4 4.5 xxxxx 
Experiment: 1 2 
Baseline: 114 121 
Hem 1 103 129 
Hem 2 105 126 
Resusc 1 80.2 106 
Resusc 2 75.4 131 
Resusc 3 79.7 106 
Resusc 4 90.1 xxxxx 
EXPERIMENTAL - DRP 
Lactate 
3 4 5 6 
1.4 0.9 1.1 1.2 
7.4 8.4 8.4 7.8 
5.3 7.8 9.5 7.2 
1.8 5 4.9 3.5 
0.9 3.8 3.2 2.8 
0.8 4.4 5.8 2.8 
1 4.9 10.2 3.1 
Glucose 
3 4 5 
184 180 184 
362 135 400 
423 66 317 
195 55 148 
169 57 105 
166 43 74 
164 29 24 
Potassium 
4 5 6 
3.7 4 3.6 
7.5 5.5 5.8 
5.7 5.4 5.1 
5.5 5 4.6 
5.5 5.2 4.6 
6.2 5.8 5.1 
7 8 4.7 
AVG 
1.35 
7.683 
7.517 
4.2 
3.467 
4.467 
4.56 
AVG 
188 
313 
307.5 
164.667 
111.667 
87.167 
95.2 
AVG 
3.7 
5.95 
5.383 
4.9 17 
5.283 
5.933 
5.68 
STD 
0.362 
0.659 
1.450 
1.489 
2.1 14 
3.367 
3.452 
STD 
15.81 1 
134.814 
187.446 
90.948 
5 1.597 
56.347 
64.325 
AVG 
99.3 
115.5 
1 16.8 
96.02 
105.183 
103.35 
102.64 
STD 
0.268 
0.846 
0.605 
0.679 
1.076 
1.837 
1.708 
STD 
15.555 
1 1.059 
7.791 
10.448 
26.035 
15.554 
13.378 
Experiment: 1 
Baseline: 41.7 
Hem 1 42.1 
Hem 2 32.9 
Resusc 1 35.7 
Resusc 2 75.4 
Resusc 3 79.7 
Resusc 4 3 1.3 
Experiment: 1 
Baseline: 97.2 
Hem 1 xxxxx 
Hem 2 94.8 
Resusc 1 87.2 
Resusc 2 84.8 
Resusc 3 91.9 
Resusc 4 93.2 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
2 
35.1 
2 1 
16.1 
23.2 
14.8 
24.2 
XXXXX 
2 
97.5 
98.6 
99 
96.6 
98.7 
90.8 
XXXXX 
2 
-4.2 
-10.7 
-13.6 
-12.1 
-13.9 
-18.9 
XXXXX 
2 
2 1.2 
17.3 
15.5 
15.9 
15.4 
10.7 
xxxxx 
Bicarbonate 
4 5 
20.7 21.8 
14 17.4 
14.5 15.1 
15.4 18 
16.2 19.4 
17.3 17.4 
16.3 12.9 
AVG 
37.9 
28.4 
24.82 
28.7 
33.617 
33.133 
25.44 
AVG 
94.26 
97.32 
96.48 
92.633 
94.25 
95.017 
95.34 
AVG 
-3.567 
-10.333 
-12.46 
-10.14 
-8.367 
-9.567 
-9.9 
AVG 
21.7 
17.083 
15.84 
17.34 
18.733 
18.1 
18.1 
STD, 
5.025 
7.459 
8.068 
5.535 
21.46 
23.456 
6.129 
STD 
3.010 
1.843 
1.635 
3.198 
4.826 
3.128 
1.812 
STD 
1.707 
2.380 
2.804 
2.574 
3.894 
5.868 
5.537 
STD 
1.073 
1.550 
1.646 
1.635 
2.457 
4.288 
3.828 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
2 
7.376 
7.41 1 
7.419 
7.35 
7.436 
7.156 
XXXXX 
Experiment: 1 2 
Baseline: 103 93 
Hem 1 47 40 
Hem 2 66 47 
Resusc 1 93 80 
Resusc 2 65 7 1 
Resusc 3 64 3 7 
Resusc 4 83 xxxxx 
Experiment: 1 2 
Baseline: 390 38 1 
Hem 1 28 1 358 
Hem 2 366 412 
Resusc 1 377 476 
Resusc 2 399 490 
Resusc 3 409 473 
Resusc 4 440 xxxxx 
Experiment: 1 2 
Baseline: 80 100 
Hem 1 52 52 
Hem 2 64 56 
Resusc 1 72 88 
Resusc 2 64 96 
Resusc 3 64 56 
Resusc 4 68 xxxxx 
MAP 
4 5 
90 105 
42 47 
48 46 
73 83 
95 88 
64 75 
52 46 
AVG 
7.367 
7.325 
7.364 
7.345 
7.386 
7.393 
7.396 
AVG 
97.167 
43.500 
52.500 
89.500 
91.333 
69.000 
68.600 
AVG 
359.833 
336.000 
390.500 
432.667 
443.500 
457.000 
44 1.600 
AVG 
72.000 
64.667 
70.333 
79.333 
79.333 
75.333 
76.000 
STD 
0.028 
0.062 
0.035 
0.014 
0.037 
0.1 18 
0.071 
STD 
6.306 
2.881 
7.583 
16.047 
22.669 
19.131 
18.257 
STD 
26.858 
49.876 
38.386 
39.480 
35.529 
33.728 
28.676 
STD 
16.589 
20.772 
9.993 
10.558 
16.860 
13.003 
16.733 
Experiment: 
Baseline: 
Hem 2 
Resusc 1 
Resusc 2 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
Experiment: 
Baseline: 
Hem 1 
Hem 2 
Resusc 1 
Resusc 2 
Resusc 3 
Resusc 4 
1 
site 1 
88.36 
59.67 
9.36 
50.47 
37.8 
30.34 
28.73 
4 
site 1 
47.21 
8.39 
5.53 
0 
0 
0 
0 
1 
site 2 
84.66 
55.71 
5 1.42 
55.54 
50.33 
58.44 
45.25 
4 
site 2 
56.7 1 
37.1 
10.77 
0 
0 
0 
0 
2 
site 1 
34.87 
12.31 
16.65 
4.88 
0.89 
1.7 1 
XXXXX 
5 
site 1 
59.55 
56.44 
59.67 
62.3 1 
8.38 
0.48 
1.34 
2 
site 2 
48.92 
3.23 
0.63 
1.64 
1.21 
0.99 
XXXXX 
5 
site 2 
50.86 
34.78 
4.25 
41.16 
13.61 
0.23 
4.86 
AVG STD 
Baseline: 60.538 17.610 
Hem 1 37.638 20.557 
Hem 2 27.483 22.620 
Resusc 1 38.687 30.203 
Resusc 2 24.059 22.936 
Resusc 3 22.18 23.922 
Resusc 4 25.248 21.686 
3 
site 1 
53.83 
40.38 
50.59 
50.81 
40.84 
45.33 
42.27 
6 
site 1 
49.12 
36.58 
29.33 
45.63 
32.58 
37.03 
35.82 
3 
site 2 
88.63 
65.36 
58.9 
92.84 
66.9 
56.67 
57.13 
6 
site 2 
63.73 
41.71 
32.69 
58.96 
36.17 
34.94 
37.08 
Hct 
1 2 3 4 5 6 AVG STD 
40.8 39.1 32.5 35.6 34.8 38.4 36.867 3.090 
26.09 13 26.7 23.16 27.7 29.7 24.392 5.977 
19.1 15.2 2 5 17.4 20.5 18.9 19.350 3.303 
17.4 12.8 19.1 17.4 15.6 17.1 16.567 2.155 
1 
14.5 
XXXXX 
9.5 
7.4 
5.9 
6.8 
6.7 
2 
12.7 
8.1 
7.9 
5.3 
5 
4.5 
XXXXX 
AVG 
13.26 
9.66 
9.24 
7.1 
5.967 
6.283 
6.55 
STD 
0.92 1 
0.99 1 
0.754 
1.279 
0.606 
0.991 
0.870 
Experiment: 1 
Baseline: 19.2 
Hem 1 xxxxx 
Hem 2 12.2 
Resusc 1 8.8 
Resusc 2 6.8 
Resusc 3 8.5 
Resusc 4 8.4 
Experiment: 1 
Baseline: 19.313 
Hem 2 12.575 
Resusc 2 16.3 
Experiment: 1 2 
Baseline: 47.6 28.1 
Hem 1 48.3 29.8 
Hem 2 49.7 29.3 
Resusc 1 46.9 21.6 
Resusc 2 38.7 21.7 
Resusc 3 38.2 22 
Resusc 4 40.3 xxxxx 
Experiment: 1 2 
Baseline: 17 13.4 
Hem 1 14.7 18.1 
Hem 2 13.4 17.5 
Resusc 1 11.5 15.6 
Resusc 2 14.7 15.4 
Resusc 3 15.2 18.1 
Resusc 4 14.9 xxxxx 
Experiment: 1 2 
Baseline: 60.2 41.4 
Hem 1 51.8 40.7 
Hem 2 66.7 41.2 
Resusc 1 58.3 26.4 
Resusc 2 65.7 29.1 
Resusc 3 43.9 32.9 
Resusc 4 48 xxxxx 
2 
16.8 
10.9 
10.6 
6.9 
6.7 
5.5 
xxxxx 
AVG 
16.9 
12.34 
11.78 
8.7 
7.6 
8.017 
8.58 
STD 
1.434 
1.405 
1.021 
1.580 
0.822 
1.375 
0.879 
RBC Velocity 
3 4 5 6 AVG STD SE 
18.875 24.706 ***** ***** 19.984 3.298 1.649 
11.638 6.319 ***** *,**** 8.711 4.023 2.012 
13.394 5.625 ***** ***** 9.855 5.918 2.959 
Arcade Diameter 
4b 5 
68.5 38.7 
67.6 35.5 
67.6 41.7 
61.4 33.1 
57.1 28.7 
58.2 27 
60.8 27.8 
Transverse Diameter 
4 4b 5 5b 6 
26 17.2 19.2 14.7 15.3 
24.6 18.7 19.1 20.5 16.3 
23 16.1 22.7 22.8 17.9 
25.9 19.3 18.2 16.6 13.8 
29.7 18 18.1 15 14.9 
24.8 20.3 20.1 15.6 16.1 
2 1 18.8 19.6 15.1 15.7 
Feed Diameter 
5 6 
***** 62.8 
***** 58.1 
***** 51.4 
***** 46.7 
***** 53.9 
***** 56.8 
***** 55.3 
AVG 
60.24 
54.28 
53.88 
44.84 
49.5 
46.68 
50.325 
STD 
18.214 
9.3 19 
10.245 
12.079 
13.390 
9.680 
6.139 
AVG 
42.929 
44.529 
45.814 
37.371 
36.386 
35.957 
38.633 
AVG 
17.225 
18.45 
18.75 
16.75 
17.287 
18.025 
16.786 
STD 
14.656 
13.991 
13.037 
13.577 
11.421 
12.310 
12.948 
STD 
3.975 
3.150 
3.638 
4.524 
5.336 
3.569 
3.070 
Diameter 
(pm) 
Flow 
Velocity Flow 
(mmls) (cm2/s) 
BL 
3.09 5.49694E-05 
2.727 2.29433E-05 
3.02 3.41554E-05 
3.953 0.00015301 1 
HEM2 
2.012 4.39389E-05 
0.69 5.74928E-06 
1.862 2.14997E-05 
1.01 1 1.883 14E-05 
RESUSC2 
2.608 5.52597E-05 
0.656 2.72684E-06 
2.143 2.25504E-05 
0.9 1.2 1767E-05 
Conversion: 
ml~microliters 
BL - AVG STD SE 
0.054969 0.06627 0.05933 0.029665 
0.022943 
0.034155 
0.153011 
HEM2 0.023729 0.015861 0.00793 
0.043939 
0.005749 
0.02 15 
0.018831 
RESUSC2 0.023 178 0.022868 0.01 1434 
0.05526 
0.002727 
0.02255 
0.012177 
APPENDIX 2 
EXPERIMENTAL DATA SHEET 
Date: Card #: Investigator: 
Birth Date: Weight: g Sex: Male 
Blood Volume = 0.06 x BW (g) = 0.06 x g = ml 
Health Status: 
ANESTHETICS: 
Anesthetic Used: 3 Ketamine/Acepromazine U Saffan 
Initial Dose: IUA 
Anesthetic Course: 
Rate of Continuous Administration (Saffan): 
Additional Anesthetics: 
PROCEDURES: 
Anesthetic Admin. 
Shave and Depilatory 
Tracheotomy 
Cannulation of R. Jugular Vein 
Cannulation of L. Carotid Artery 
Cannulation of R. Femoral Vein 
Cannulation of L. Femoral Vein 
Spinotrapezius Prep 
UPd- Porphyrin Wrap 
U Map Microvascular Network 
~ i c r o s c o ~ e  Magnification: 20x 
Baseline Measurements 
MAP C HR 7 Respirations 
OABG 
p H  Lactic Acid K 
PC02 O2 Sat Hct 
Po2 Na [Hb] 
Arteriole Diameter: pm RBC Velocity: mmlsec Interstitial PO2 mmHg 
Feed Feed Site 11s~  PO2 
Arcade 
Transverse Site &SF P02 
Hemorrha~e Protocol: 
MAKE SURE THAT THE DIAMETER FOR THE SYRINGE IS SET TO 14.46mm 
Hemorrhage Volume = 0.40 x BV = 0.40 x ml = - ml 
Step 1 0.50 x HV ml at 0.5 mllmin min 
Step 2 0.25 x HV ml at 0.25 mllmin min 
Step 3 0.25 x HV ml at 0.15 mllmin min 
Total Hemorrhage Time 
Hemorrhage Measurement 1 (after end of hemorrhage) 
OMAP C HR Respirations 
C ABG 
2 H  Lactic Acid K 
PC02 0 2  Sat [Hbl 
Po2 Na 
Arteriole Diameter: pm Interstitial PO2 mmHg 
Feed Arcade Site 1 1 s ~  PO2 
Transverse Site PO2 
Hemorrhage Measurement 2 (30 rnin after first measurements) 
O MAP C HR Respirations 
q ABG 
p H  Lactic Acid K 
PC02 0 2  Sat Hct 
Po2 Na [Hbl 
Arteriole Diameter: pm RBC Velocity: rnmlsec Interstitial PO2 m I H g  
Feed Feed Site lIsF PO2 
Arcade 
Transverse Site PO2 
Bepin Resuscitation 1 hour from end of Hemorrha~e 
Resuscitation Protocol: 
MAKE SURE THAT THE DIAMETER FOR THE SYRINGE IS SET TO 14.40mm 
3X Hemorrhage volume with Ringer's Lactate over 1 hour 
Resuscitation Rate = [3(Hemorrhage BV)]1 60 rnin = [3( ml)]/ 60 rnin 
Resuscitation Rate = mV 60 min = mllmin 
30 Min. 
OMAP CHR C Respirations 
OABG 
p H  Lactic Acid K 
PC02 0 2  Sat Hct 
Arteriole Diameter: pm Interstitial PO2 mrnHg 
Feed Arcade Site 11s~  PO2 
Transverse Site PO2 
60 Min. 
OMAP 1 HR U Respirations 
q ABG 
p H  Lactic Acid K 
PC02 0 2  Sat Hct 
Po2 Na [Hbl 
Arteriole Diameter: pm RBC Velocity: mm/sec Interstitial PO2 mmHg 
Feed Feed Site 1 ISF PO2 
Arcade 
Transverse Site &SF PO2 
90 Min. 
OMAP OHR Respirations 
CABG 
p H  Lactic Acid K 
PC02 0 2  Sat [Hbl 
Po2 Na 
Arteriole Diameter: pm Interstitial PO2 mrnHg 
Feed Arcade Site l I s ~  PO2 
Transverse Site PO2 
120 Min. 
U MAP !IHR C Respirations 
OABG 
DH Lactic Acid K 
I
PC02 0 2  Sat [Hbl 
Po2 Na 
Arteriole Diameter: pm Interstitial PO2 mmHg 
Feed Arcade Site 11s~  PO2 
Transverse Site PO2 
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